Optherion Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

Optherion General Information

Description

Operator of a biotechnology company intended for the advancement of diagnostic tools and disease-modifying therapeutics. The company is aimed at effectively managing and treating early-stage age-related macular degeneration, dense deposit disease, also known as membranoproliferative glomerulonephritis, atypical hemolytic uremic syndrome, and other chronic diseases associated with the alternative complement cascade, enabling scientific researchers that have identified specific genes linked to various renal diseases and prevalent among individuals over the age of 60 in developed countries, stands as the primary cause of blindness.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 11th Floor 555 Long Wharf Drive
  • The Maritime Center
  • New Haven, CT 06511
  • United States
+1 (203)
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 11th Floor 555 Long Wharf Drive
  • The Maritime Center
  • New Haven, CT 06511
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optherion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 01-Jun-2020 Completed Generating Revenue
6. Early Stage VC 16-Sep-2009 Completed Generating Revenue
5. Merger/Acquisition 31-Mar-2009 Completed Startup
4. Early Stage VC 14-Jan-2009 Completed Startup
3. Grant 01-Jan-2009 Completed Startup
2. Early Stage VC (Series A1) 09-Oct-2007 $37.5M $37.8M Completed Startup
1. Early Stage VC 13-Apr-2007 $250K $250K Completed Startup
To view Optherion’s complete valuation and funding history, request access »

Optherion Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
To view Optherion’s complete cap table history, request access »

Optherion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Optherion Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biogen Corporation Minority
Domain Associates Venture Capital Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Knoa Pharma Corporation Minority
Pappas Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Optherion FAQs

  • When was Optherion founded?

    Optherion was founded in 2005.

  • Where is Optherion headquartered?

    Optherion is headquartered in New Haven, CT.

  • What is the size of Optherion?

    Optherion has 5 total employees.

  • What industry is Optherion in?

    Optherion’s primary industry is Diagnostic Equipment.

  • Is Optherion a private or public company?

    Optherion is a Private company.

  • What is Optherion’s current revenue?

    The current revenue for Optherion is .

  • How much funding has Optherion raised over time?

    Optherion has raised $5M.

  • Who are Optherion’s investors?

    Biogen, Domain Associates, Johnson & Johnson JJDC, Knoa Pharma, and Pappas Capital are 5 of 8 investors who have invested in Optherion.

  • When was Optherion acquired?

    Optherion was acquired on 01-Jun-2020.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process